Subscribe
shutterstock_1524073421_karol_ciesluk
Karol Ciesluk / Shutterstock.com
27 February 2020AmericasSarah Morgan

Vir Biotech partners with WuXi on COVID-19 antibody treatment

Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.


Editor's picks

Trouble at the USPTO—Part II: Bracing for impact
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025

Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025
Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

More features

Mental health IP toolkit: WIPR Diversity Champ’s stress-busting tips
Eli Lilly piles on weight loss drug suits to ward off revenue squeeze
Patent cliff: 5 blockbusters running out of road
Herbert Smith Freehills expands German tech patent team
‘Always new twists’: Bayer legal team on defending a $4bn drug
Novartis and MSN feud intensifies after Fed Circ denies rehearing
EU court signals tough stance on ‘pay-for-delay’ pharma deals
Panitch Schwarze hires experienced ex-USPTO examiner